In this review:
Biomarker analyses from NeoSphere
Pertuzumab, trastuzumab and anthracyclines
Pertuzumab improves PFS in metastatic HER2+ breast cancer
Neratinib: high anti-tumour activity
Adjuvant zoledronic acid: long-term benefits in ABCSG-12
ZO-FAST: benefits of zoled
Please login below to download this issue (PDF)